Neuroleptics

Neuroleptics, also known as antipsychotics, are medications primarily used to manage behavioral symptoms like agitation, aggression, and psychosis in Alzheimer's disease and dementia patients. However, their use is controversial due to potential side effects such as sedation, increased risk of falls, and cognitive decline. Neuroleptics work by blocking dopamine receptors in the brain, which can help alleviate symptoms but may also worsen cognitive function in elderly individuals already vulnerable to cognitive impairment.

Recent guidelines emphasize cautious and limited use of neuroleptics, preferring non-pharmacological approaches first. Behavioral interventions, environmental modifications, and caregiver education are preferred strategies to manage challenging behaviors. When neuroleptics are prescribed, it is crucial to monitor their effects closely and consider the individual's overall health and specific needs. Balancing the benefits against potential risks remains essential in optimizing care for Alzheimer's and dementia patients.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp